| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/17/2001 | CA2388729A1 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
| 05/17/2001 | CA2388643A1 Use of lytic toxins and toxin conjugates |
| 05/17/2001 | CA2388477A1 Recombinant gelatins with uniform molecular weight |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/17/2001 | CA2387964A1 22 human secreted proteins |
| 05/17/2001 | CA2387959A1 21 human secreted proteins |
| 05/17/2001 | CA2361139A1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods |
| 05/16/2001 | EP1099759A2 Vibrio cholerae vaccine candidates and methods of their constructing |
| 05/16/2001 | EP1099700A1 Crystalline oxathiolane derivatives |
| 05/16/2001 | EP1098985A1 Genes of the dead box protein family, their expression products and use |
| 05/16/2001 | EP1098981A1 A mutant human hepatitis b viral strain and uses thereof |
| 05/16/2001 | EP1098969A2 Use of nucleic acid molecules as antiviral agents |
| 05/16/2001 | EP1098961A1 Interferon inducing genetically engineered attenuated viruses |
| 05/16/2001 | EP1098910A1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders |
| 05/16/2001 | EP1098908A2 Anti-ccr2 antibodies and methods of use therefor |
| 05/16/2001 | EP1098901A1 Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines |
| 05/16/2001 | EP1098898A1 Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3- (4-aminophenyl) sulfonyl] (isobutyl) amino] -1-benzyl-2- (phosphonooxy) propylcarbamate |
| 05/16/2001 | EP1098884A1 Il-8 receptor antagonists |
| 05/16/2001 | EP1098663A1 Slow release formulations comprising anionic polysaccharide |
| 05/16/2001 | EP1098654A1 Antilipemic composition comprising a polysaccharide containing glucuronic acid |
| 05/16/2001 | EP1098644A1 Substituted benzimidazole antiviral agents |
| 05/16/2001 | EP1098640A1 Anti-ulcer composition comprising a polysaccharide containing glucuronic acid |
| 05/16/2001 | EP1098635A1 Enteric coated pharmaceutical tablet and method of manufacturing |
| 05/16/2001 | EP1098633A1 Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose |
| 05/16/2001 | EP1084709A9 Oral recombinant lactobacilli vaccines |
| 05/16/2001 | CN1295623A Self-replicating vector for DNA immunication against HIV |
| 05/16/2001 | CN1295620A Protein expression in baculovirus vector expression system |
| 05/16/2001 | CN1295614A Modulator for function of receptor of TNF/NGF receptor family and other protein |
| 05/16/2001 | CN1295573A Pharmaceutically available protoberberine salt derivatives, and protoberberine derivatives and salt thereof |
| 05/16/2001 | CN1295566A Trisubstituted 1,3,5-triazine derivatives for treatment by HIV infections |
| 05/16/2001 | CN1295564A HIV inhibiting pyrimidine derivatives |
| 05/16/2001 | CN1295484A Formulations for protection of PEG-interferon alpha conjugates |
| 05/16/2001 | CN1295483A Gelling ophthalmic composition containing xanthan gum |
| 05/16/2001 | CN1295481A 疫苗组合物 Vaccine composition |
| 05/16/2001 | CN1295480A Vaccines comprising interleukin-12 and respiratory syncytial viral antigens |
| 05/16/2001 | CN1295465A Quinolone-containing liposome composition |
| 05/16/2001 | CN1295460A Polyalkoxy copolymers as lipase inhibitors and their composition |
| 05/16/2001 | CN1295456A Acidified composition for topical treatment of nail and skin conditions |
| 05/16/2001 | CN1295077A Intermediate of ganglioside GM3 analogue using fluorine to substitute sialic acid at 9-position |
| 05/16/2001 | CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor |
| 05/16/2001 | CN1294915A Medicine powder for treating beri-beri, smelly foot and sweaty foot |
| 05/16/2001 | CN1294911A Substituted nitrobenzene derivative for medicine and other use |
| 05/16/2001 | CN1065862C N-(2-amino-4, 6-pyrimidine bichloride-5-) formamide and preparation of same |
| 05/16/2001 | CN1065749C Medicine for treating hepatitis and tuberculosis |
| 05/15/2001 | US6232449 Persephin and related growth factors |
| 05/15/2001 | US6232349 And polycarbonates, polyesters or polyamides water-soluble, with a rigid backbone and predictable anion spacing |
| 05/15/2001 | US6232315 Method for treating inflammatory diseases by administering a thrombin inhibitor |
| 05/15/2001 | US6232308 Useful for inhibiting bone resorption, treating and preventing osteoporosis, inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, and angiogenesis |
| 05/15/2001 | US6232306 Useful as antibiotics especially against methicillin resistant staphylcocci and pseudomonas species |
| 05/15/2001 | US6232305 Substituted amino bicyclic-β-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 05/15/2001 | US6232300 Administering as hepatitis b viricide |
| 05/15/2001 | US6232292 3-dehydroquinate synthase |
| 05/15/2001 | US6232290 Cyclic hexapeptides with antimicrobial activity |
| 05/15/2001 | US6232097 Nucleotide sequences coding enzymatic polypeptide; prevent bacterial infection; wound healing agents; for vaccine development |
| 05/15/2001 | US6231887 Drugs of pyranone derivatives |
| 05/15/2001 | US6231878 Spraying acid water and electrolysis, oxidation-reduction potentials for skins |
| 05/15/2001 | US6231875 Acidified composition for topical treatment of nail and skin conditions |
| 05/15/2001 | US6231871 Live in ovo vaccine |
| 05/15/2001 | US6231870 Oral administration of pneumoccal antigens |
| 05/15/2001 | US6231869 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 05/15/2001 | US6231864 Strategically modified hepatitis B core proteins and their derivatives |
| 05/15/2001 | US6231863 DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 05/15/2001 | US6231860 Stabilizers for live vaccines |
| 05/15/2001 | US6231848 N-vinyllactam homo or copolymer complexed with hydrogen peroxide and colloidal silver or silver salt useful as prophylaxis agent |
| 05/15/2001 | CA2238978C Retroviral protease inhibiting compounds |
| 05/15/2001 | CA2196539C Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
| 05/10/2001 | WO2001033221A1 Axor35, a g-protein coupled receptor |
| 05/10/2001 | WO2001032900A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 05/10/2001 | WO2001032893A1 Recombinant therapeutic fusion proteins |
| 05/10/2001 | WO2001032888A2 Human transferase molecules |
| 05/10/2001 | WO2001032882A2 Nucleic acids and proteins from group b streptococcus |
| 05/10/2001 | WO2001032877A2 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 05/10/2001 | WO2001032867A1 Polypeptides with expanded primary signalling motifs |
| 05/10/2001 | WO2001032866A2 Hybrid adaptor receptors |
| 05/10/2001 | WO2001032865A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | WO2001032851A2 Modular transport systems for molecular substances and production and use thereof |
| 05/10/2001 | WO2001032831A2 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 05/10/2001 | WO2001032713A1 Production of mammary secretion antibodies in farm animals |
| 05/10/2001 | WO2001032709A2 Polypeptides with non-natural primary signalling motifs |
| 05/10/2001 | WO2001032691A1 Hcv ns3 protease inhibitors |
| 05/10/2001 | WO2001032690A1 Substituted dipeptides having nos inhibiting activity |
| 05/10/2001 | WO2001032687A1 10 human secreted proteins |
| 05/10/2001 | WO2001032677A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | WO2001032675A1 32 human secreted proteins |
| 05/10/2001 | WO2001032674A1 26 human secreted proteins |
| 05/10/2001 | WO2001032663A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 05/10/2001 | WO2001032658A1 Polyazanaphthalene compound and medicinal use thereof |
| 05/10/2001 | WO2001032657A1 Antibiotic sultam and sultone derived oxazolidinones |
| 05/10/2001 | WO2001032655A2 Quinoline and naphthyridine carboxylic acid antibacterials |
| 05/10/2001 | WO2001032654A2 Novel heterocyclic compounds and their use as medicines |
| 05/10/2001 | WO2001032653A1 Heterocyclic substituted pyrazolones |
| 05/10/2001 | WO2001032652A2 N-substituted carbamoyloxyalkyl-azolium derivatives |
| 05/10/2001 | WO2001032650A2 Alkaline salts of n-(6-alkyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinesulfone)-n'-isonicotinoylhydrazide, possess for their preparation, and pharmaceutical composition based on these salts |
| 05/10/2001 | WO2001032633A1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 05/10/2001 | WO2001032631A2 Heterocyclic cytotoxic agents |
| 05/10/2001 | WO2001032629A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 05/10/2001 | WO2001032618A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 05/10/2001 | WO2001032614A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | WO2001032606A1 Compounds having mif antagonist activity |
| 05/10/2001 | WO2001032596A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents |